Brilliant news: Hvorostovsky will sing again at the Met

Brilliant news: Hvorostovsky will sing again at the Met


norman lebrecht

September 03, 2015

The Russian baritone, who is undergoing treatment for a brain tumour, has decided after all to sing his two opening performances at the Met this season. Met announcement below.


dmitri hvorostovsky

Dmitri Hvorostovsky has withdrawn from three performances of Verdi’s Il Trovatore at the Met this season, on October 7, 10, and 17. Hvorostovsky, who was diagnosed with a brain tumor in June, will sing the opening performances of the opera at the Met as scheduled (September 25 and 29, and October 3 matinee), then return to London for  continued treatment.

Vitaliy Bilyy will sing di Luna on October 7, 10, and 17, a role he performed at the Met in 2010. The Ukrainian baritone made his Met debut in 2007 as Denisov in Prokofiev’s War and Peace and has also sung Shaklovity in Mussorsgky’s Khovanshchina with the company. He has sung di Luna at the Bavarian State Opera, Toulouse’s Théâtre du Capitol, and the Teatro Municipal in Santiago, Chile.

The fall performances of Il Trovatore are conducted by Marco Armiliato and also star Anna Netrebko as Leonora, Dolora Zajick as Azucena, Yonghoon Lee and Antonello Palombi as Manrico, and Štefan Kocán as Ferrando.


  • John Borstlap says:

    A beautiful sign that sometimes there is something like justice in this world. May this great singer make a full recovery.

  • Emil says:

    “September 25 and 29, and October 3 matinee),”…his “two” opening performances?

  • Pamela Peled says:

    I would like to add my good wishes for a full recovery for this wonderful singer. It is very courageous of him to undertake these taxing performances while treatment is pending, and I do hope they will not drain the strength he will undoubtedly need over the next months. May he return to us soon in full health.

  • Marlene Handler says:

    I am thrilled that Hvorostovsky is returning to the Met. What a grand accomplishment in view of the serious nature of his treatment. BRAVO